Tag: NSAID

Articles

• Aspirin and breast cancer
• Morphine during surgery might increase risk of metastasis

News

04/18/15

Aspirin reduces growth and self-renewal capacity of BC stem cells

08/10/14

Aspirin use is linked to improved breast cancer survival

11/21/11

Use of NSAIDs before diagnosis does not improve BC survival

07/11/11

Taking Celebrex might reduce effectiveness of chemotherapy

04/28/11

Aspirin linked to reduced BC risk, but ibuprofen may increase it

Studies

• The relationship between nonsteroidal anti-inflammatory drugs and cancer incidence: An umbrella review Cite
  Wang P, Chen B, Huang Y, Li J, Cao D, Chen Z, et al. The relationship between nonsteroidal anti-inflammatory drugs and cancer incidence: An umbrella review. Heliyon. Elsevier BV; 2024;:e23203 10.1016/j.heliyon.2023.e23203
• Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Baker A, Kartsonaki C. Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis. The Oncologist. Oxford University Press (OUP); 2023; 10.1093/oncolo/oyad186
• Abstract P4-03-02: Low-dose aspirin prescriptions and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up Cite
  Solmunde E, Pedersen RN, Nørgaard M, Mellemkjær L, Friis S, Ejlertsen B, et al. Abstract P4-03-02: Low-dose aspirin prescriptions and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:P4-03-02-P4-03-02 10.1158/1538-7445.sabcs22-p4-03-02
• Aspirin for the primary prevention of breast cancer: an unforeseen advantage Cite
  Sheikh A, Masood Z, Abro K, Malik F, Ali E. Aspirin for the primary prevention of breast cancer: an unforeseen advantage. International Journal of Surgery: Global Health. Ovid Technologies (Wolters Kluwer Health); 2023; 6:e101-e101 10.1097/gh9.0000000000000101
• Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort Cite
  Sherman ME, Vierkant RA, Masters M, Radisky DC, Winham SJ, Degnim AC, et al. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort. Cancer Prevention Research. American Association for Cancer Research (AACR); 2023; 10.1158/1940-6207.capr-22-0403
• Aspirin Use is Associated with Improvement in Distant Metastases Outcome in Patients with Residual Disease after Neoadjuvant Chemotherapy Cite
  Johns C, Cauble M, Liu Y, Rahimi A, Alluri P, Nwachukwu C, et al. Aspirin Use is Associated with Improvement in Distant Metastases Outcome in Patients with Residual Disease after Neoadjuvant Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2022; 114:e5 10.1016/j.ijrobp.2022.07.683
• NSAIDs Induce Proline Dehydrogenase/Proline Oxidase-Dependent and Independent Apoptosis in MCF7 Breast Cancer Cells Cite
  Kazberuk A, Chalecka M, Palka J, Bielawska K, Surazynski A. NSAIDs Induce Proline Dehydrogenase/Proline Oxidase-Dependent and Independent Apoptosis in MCF7 Breast Cancer Cells. International Journal of Molecular Sciences. MDPI AG; 2022; 23:3813 10.3390/ijms23073813
• Abstract P2-11-01: Breast cancer (BC) risk among patients with benign breast disease (BBD) by NSAID use Cite
  Vierkant RA, Masters M, Teras LR, Sherman ME. Abstract P2-11-01: Breast cancer (BC) risk among patients with benign breast disease (BBD) by NSAID use. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P2-11-01-P2-11-01 10.1158/1538-7445.sabcs21-p2-11-01
• A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial Cite
  Chen WY, Ballman KV, Winer EP, Openshaw TH, Hahn OM, Briccetti FM, et al. A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:360922-360922 10.1200/jco.2022.40.36_suppl.360922
• Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination Cite
  McCormick PJ, Assel M, Van Zee KJ, Vickers AJ, Nelson JA, Morrow M, et al. Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 28:5134-5140 10.1245/s10434-021-09722-4
• Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer Cite
  Bhardwaj A, Embury MD, Rojo RD, Albarracin C, Bedrosian I. Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer. Breast Cancer Research and Treatment; 2021; 10.1007/s10549-021-06229-0
• Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women Cite
  Cairat M, Al Rahmoun M, Gunter MJ, Severi G, Dossus L, Fournier A. Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021; 30:643-652 10.1158/1055-9965.epi-20-1292
• Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019 Cite
  Ma S, Guo C, Sun C, Han T, Zhang H, Qu G, et al. Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.02.005
• Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy Cite
  Sherman ME, Vierkant RA, Kaggal S, Hoskin TL, Frost MH, Denison L, et al. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy. Cancer Prevention Research. American Association for Cancer Research (AACR); 2020; 13:967-976 10.1158/1940-6207.capr-20-0178
• Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women Cite
  Cairat M, Al Rahmoun M, Gunter MJ, Severi G, Dossus L, Fournier A. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-01343-1
• Aspirin use and risk of breast cancer in African American women Cite
  Bertrand KA, Bethea TN, Gerlovin H, Coogan PF, Barber L, Rosenberg L, et al. Aspirin use and risk of breast cancer in African American women. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-01335-1
• Effect of aspirin on cancer incidence and mortality in older adults Cite
  McNeil JJ, Gibbs P, Orchard SG, Lockery JE, Bernstein WB, Cao Y, et al. Effect of aspirin on cancer incidence and mortality in older adults. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 10.1093/jnci/djaa114
• Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease Cite
  Degnim A, Vierkant R, Winham S, Frost M, Visscher D, Carter J, et al. Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p5-08-06
• Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study Cite
  Wang T, McCullough LE, White AJ, Bradshaw PT, Xu X, Cho YH, et al. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study. Cancer. Wiley; 2019; 125:3836-3844 10.1002/cncr.32364
• Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study Cite
  Kehm RD, Hopper JL, John EM, Phillips K, MacInnis RJ, Dite GS, et al. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1135-y
• Aspirin suppresses tumor cell-induced angiogenesis and their incongruity Cite
  Maity G, Chakraborty J, Ghosh A, Haque I, Banerjee S, Banerjee SK. Aspirin suppresses tumor cell-induced angiogenesis and their incongruity. Journal of Cell Communication and Signaling. Springer Science and Business Media LLC; 2019; 13:491-502 10.1007/s12079-018-00499-y
• No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study Cite
  Frisk G, Ekberg S, Lidbrink E, Eloranta S, Sund M, Fredriksson I, et al. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1065-0
• Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study Cite
  Bens A, Friis S, Dehlendorff C, Jensen M, Ejlertsen B, Kroman N, et al. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study. Preventive Medicine. Elsevier BV; 2018; 116:186-193 10.1016/j.ypmed.2018.09.015
• Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27 Cite
  Strasser-Weippl K, Higgins MJ, Chapman JW, Ingle JN, Sledge GW, Budd GT, et al. Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 110:1003-1008 10.1093/jnci/djy017
• The impact of aspirin use on breast cancer subtype and clinical course Cite
  Williams AD, Li YR, So A, Steel L, Carrigan E, Ro V, et al. The impact of aspirin use on breast cancer subtype and clinical course. Journal of Surgical Research. Elsevier BV; 2018; 230:71-79 10.1016/j.jss.2018.04.040
• Nonsteroidal anti‐inflammatory drug use and breast cancer risk in a European prospective cohort study Cite
  Cairat M, Fournier A, Murphy N, Biessy C, Scalbert A, Rinaldi S, et al. Nonsteroidal anti‐inflammatory drug use and breast cancer risk in a European prospective cohort study. International Journal of Cancer. Wiley; 2018; 143:1688-1695 10.1002/ijc.31570
• The effects of celecoxib on the proliferation and ultrastructural changes of MDA-MB-231 breast cancer cells Cite
  Ma Q, Gao Y, Wei D, Jiang N, Ding L, He X, et al. The effects of celecoxib on the proliferation and ultrastructural changes of MDA-MB-231 breast cancer cells. Ultrastructural Pathology. Informa UK Limited; 2018; 42:289-294 10.1080/01913123.2018.1459996
• Pre-diagnostic aspirin use and mortality after breast cancer Cite
  Wang T, Parada H, McClain KM, Bradshaw PT, Terry MB, Teitelbaum SL, et al. Pre-diagnostic aspirin use and mortality after breast cancer. Cancer Causes & Control. Springer Science and Business Media LLC; 2018; 29:417-425 10.1007/s10552-018-1020-5
• Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity Cite
  Huang C, Chen Y, Liu H, Yang J, Song X, Zhao J, et al. Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity. Oncotarget. Impact Journals, LLC; 2017; 8:115254-115269 10.18632/oncotarget.23250
• Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals Cite
  Dandah O, Najafzadeh M, Isreb M, Linforth R, Tait C, Baumgartner A, et al. Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. Elsevier BV; 2018; 826:41-46 10.1016/j.mrgentox.2017.12.001
• Abstract 3012: Long-term aspirin use and total and cancer-specific mortality Cite
  Cao Y, Stampfer M, Willett W, Spiegelman D, Manson J, Rimm E, et al. Abstract 3012: Long-term aspirin use and total and cancer-specific mortality. Epidemiology. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-3012
• Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan Cite
  Yang Y, Kornelius E, Chiou J, Lai Y, Lo S, Peng C, et al. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan. Journal of Women's Health. Mary Ann Liebert Inc; 2017; 26:1278-1284 10.1089/jwh.2016.6040
• Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway Cite
  Liu B, Yan S, Qu L, Zhu J. Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. Cancer Cell International. Springer Science and Business Media LLC; 2017; 17 10.1186/s12935-016-0378-2
• Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients Cite
  Shiao J, Thomas KM, Rahimi AS, Rao R, Yan J, Xie X, et al. Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 161:463-471 10.1007/s10549-016-4081-8
• The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size Cite
  Simonsson M, Björner S, Markkula A, Nodin B, Jirström K, Rose C, et al. The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size. International Journal of Cancer. Wiley; 2016; 140:163-175 10.1002/ijc.30432
• Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study Cite
  Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, et al. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2692-4
• Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cite
  Bradley MC, Black A, Freedman AN, Barron TI. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer. Wiley; 2016; 122:2067-2075 10.1002/cncr.30004
• Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies Cite
  Elwood PC, Morgan G, Pickering JE, Galante J, Weightman AL, Morris D, et al. Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0152402 10.1371/journal.pone.0152402
• Fish oil augments celecoxib mediated alteration in apoptotic pathway in the initiation phase of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis Cite
  Negi AK, Bhatnagar A, Agnihotri N. Fish oil augments celecoxib mediated alteration in apoptotic pathway in the initiation phase of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis. Biomedicine & Pharmacotherapy. Elsevier BV; 2016; 79:9-16 10.1016/j.biopha.2016.01.032
• Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator Cite
  Yin T, Wang G, Ye T, Wang Y. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep19534
• Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity Cite
  Zelenay S, van der Veen A, Böttcher J, Snelgrove K, Rogers N, Acton S, et al. Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity. Cell. Elsevier BV; 2015; 162:1257-1270 10.1016/j.cell.2015.08.015
• Piroxicam, a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS mediated Akt activation Cite
  Rai N, Sarkar M, Raha S. Piroxicam, a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS mediated Akt activation. Pharmacological Reports. Springer Science and Business Media LLC; 2015; 67:1215-1223 10.1016/j.pharep.2015.05.012
• Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition Cite
  Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Laboratory Investigation. Springer Science and Business Media LLC; 2015; 95:702-717 10.1038/labinvest.2015.49
• Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis Cite
  Huang X, Gao P, Sun J, Song Y, Tsai C, Liu J, et al. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. Cancer Causes & Control. Springer Science and Business Media LLC; 2015; 26:589-600 10.1007/s10552-015-0539-y
• Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis Cite
  de Pedro M, Baeza S, Escudero M, Dierssen-Sotos T, Gómez-Acebo I, Pollán M, et al. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 149:525-536 10.1007/s10549-015-3267-9
• NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin–Aromatase Interactions Cite
  Bowers LW, Maximo IX, Brenner AJ, Beeram M, Hursting SD, Price RS, et al. NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin–Aromatase Interactions. Cancer Research. American Association for Cancer Research (AACR); 2014; 74:4446-4457 10.1158/0008-5472.can-13-3603
• Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women Cite
  Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Cai H, Fair AM, et al. Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 146:439-446 10.1007/s10549-014-3030-7
• Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery Cite
  Forget P, Bentin C, Machiels J, Berliere M, Coulie P, De Kock M. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. British Journal of Anaesthesia. Elsevier BV; 2014; 113:i82-i87 10.1093/bja/aet464
• Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy Cite
  Holmes CE, Jasielec J, Levis JE, Skelly J, Muss HB. Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy. Clinical and Translational Science. Wiley; 2013; 6:386-390 10.1111/cts.12070
• Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model Cite
  Na Y, Yoon Y, Son D, Seok S. Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e63451 10.1371/journal.pone.0063451
• Cancer surgery induces inflammation, immunosuppression and neo-angiogenesis, but is it influenced by analgesics? Cite
  Forget P, Simonet O, De Kock M. Cancer surgery induces inflammation, immunosuppression and neo-angiogenesis, but is it influenced by analgesics?. F1000Research. F1000 Research Ltd; 2013; 2:102 10.12688/f1000research.2-102.v1
• Direct regulation of caspase-3 by the transcription factor AP-2α is involved in aspirin-induced apoptosis in MDA-MB-453 breast cancer cells Cite
  YAN F, HE Q, HU X, LI W, WEI K, LI L, et al. Direct regulation of caspase-3 by the transcription factor AP-2α is involved in aspirin-induced apoptosis in MDA-MB-453 breast cancer cells. Molecular Medicine Reports. Spandidos Publications; 2013; 7:909-914 10.3892/mmr.2013.1257
• Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells Cite
  JEON Y, SUH YJ. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells. Oncology Reports. Spandidos Publications; 2012; 29:819-825 10.3892/or.2012.2158
• Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence Cite
  Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE. Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:3468-3477 10.1200/jco.2012.42.2006
• Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2010; 21:1503-1512 10.1007/s10552-010-9579-5
• NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals Cite
  Kodela R, Chattopadhyay M, Kashfi K. NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals. ACS Medicinal Chemistry Letters. American Chemical Society (ACS); 2012; 3:257-262 10.1021/ml300002m
• Naproxen aggravates doxorubicin-induced cardiomyopathy in rats Cite
  Pathan R, Singh B, Pillai K, Dubey K. Naproxen aggravates doxorubicin-induced cardiomyopathy in rats. Indian Journal of Pharmacology. Medknow; 2010; 42:44 10.4103/0253-7613.62411
• Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis Cite
  Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, et al. Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 21:239-242 10.1158/1055-9965.epi-11-1012
• Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells Cite
  El-Awady RA, Saleh EM, Ezz M, Elsayed AM. Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells. Toxicology and Applied Pharmacology. Elsevier BV; 2011; 255:271-286 10.1016/j.taap.2011.06.019
• Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes & Control. Springer Science and Business Media LLC; 2011; 22:965-975 10.1007/s10552-011-9769-9
• Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study Cite
  Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, et al. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 126:149-155 10.1007/s10549-010-1074-x
• Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis Cite
  Forget P, Vandenhende J, Berliere M, Machiels J, Nussbaum B, Legrand C, et al. Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis. Anesthesia & Analgesia. Ovid Technologies (Wolters Kluwer Health); 2010; 110:1630-1635 10.1213/ane.0b013e3181d2ad07
• Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis Cite
  Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, et al. Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:627-637 10.1093/jnci/djq101
• Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women Cite
  Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE. Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:1033-1041 10.1158/1055-9965.epi-09-0975
• Aspirin Intake and Survival After Breast Cancer Cite
  Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin Intake and Survival After Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1467-1472 10.1200/jco.2009.22.7918
• Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model Cite
  Tran-Thanh D, Buttars S, Wen Y, Wilson C, Done SJ. Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model. Cancer Prevention Research. American Association for Cancer Research (AACR); 2010; 3:202-211 10.1158/1940-6207.capr-09-0181
• Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study Cite
  Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, et al. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study. Breast Cancer Research. Springer Science and Business Media LLC; 2008; 10 10.1186/bcr2089
• Antibiotic Use in Relation to the Risk of Breast Cancer Cite
  Velicer CM. Antibiotic Use in Relation to the Risk of Breast Cancer. JAMA. American Medical Association (AMA); 2004; 291:827 10.1001/jama.291.7.827
• Effect of Red Clover Isoflavones on Cox-2 Activity in Murine and Human Monocyte/Macrophage Cells Cite
  Lam ANC, Demasi M, James MJ, Husband AJ, Walker C. Effect of Red Clover Isoflavones on Cox-2 Activity in Murine and Human Monocyte/Macrophage Cells. Nutrition and Cancer. Informa UK Limited; 2004; 49:89-93 10.1207/s15327914nc4901_12